Dr. med. Dennis Kannenkeril



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Early vascular parameters in the micro- and macrocirculation in type 2 diabetes (2018) Kannenkeril D, Bosch A, Harazny J, Karg M, Jung S, Ott C, Schmieder R Journal article SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial (2018) Karg M, Bosch A, Kannenkeril D, Striepe K, Ott C, Schneider MP, Boemke-Zelch F, et al. Journal article Reduction of tissue sodium content by SGLT-2-inhibition with dapagliflozin (2017) Karg MV, Ott C, Linz P, Jumar A, Kannenkeril D, Titze J, Hammon M, et al. Conference contribution COPEPTIN LEVELS IN PATIENTS WITH TREATMENT RESISTANT HYPERTENSION BEFORE AND AFTER RENAL DENERVATION (2017) Jumar A, Ott C, Schmid A, Kannenkeril D, Ditting T, Veelken R, Uder M, Schmieder R Conference contribution Retinal vascular resistance in arterial hypertension (2017) Kannenkeril D, Harazny JM, Bosch A, Ott C, Michelson G, Schmieder R, Friedrich S Journal article Effects of the Selective Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin on Vascular Function and Central Hemodynamics in Patients With Type 2 Diabetes Mellitus (2017) Striepe K, Jumar A, Ott C, Karg M, Schneider M, Kannenkeril D, Schmieder R Journal article Experience with belatacept rescue therapy in kidney transplant recipients (2016) Brakemeier S, Kannenkeril D, Duerr M, Braun T, Bachmann F, Schmidt D, Wiesener M, Budde K Journal article A diet rich in Mailllard reaction products protects LDL against copper induced oxidation ex vivo, a human intervention trial (2009) Dittrich R, Dragonas C, Kannenkeril D, Hoffmann I, Müller A, Beckmann M, Pischetsrieder M Journal article